XBIO · Company research
Xenetic Biosciences, Inc. (XBIO): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| XBIO Forecast — Price Target — Prediction for 2027 - TradingView | XBIO Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Oct 20, 2026 | neutral | 0 | 0.6 |
| A lymphoma patient is first in a 12-person study to get a DNA-cutting enzyme with immune-cell cancer treatment. - Stock Titan | A lymphoma patient is first in a 12-person study to get a DNA-cutting enzyme with immune-cell cancer treatment. Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| Xenetic Biosciences, Inc. (XBIO) Stock Price, News, Quote & History - Yahoo Finance | Xenetic Biosciences, Inc. (XBIO) Stock Price, News, Quote & History Yahoo Finance | View source ↗ | Yahoo Finance | Oct 14, 2026 | neutral | 0 | 0.6 |
| Xenetic Biosciences (XBIO) Ticks Higher to $2.24 as Shares Hold Above Key Support - Dividend Stock Picks - https://www.siam.in/ | Xenetic Biosciences (XBIO) Ticks Higher to $2.24 as Shares Hold Above Key Support - Dividend Stock Picks https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 5, 2026 | neutral | 0 | 0.6 |
| Santersus holders could own about 85% of the combined company in Xenetic Biosciences (XBIO)'s pending exchange. - Stock Titan | Santersus holders could own about 85% of the combined company in Xenetic Biosciences (XBIO)'s pending exchange. Stock Titan | View source ↗ | Stock Titan | Sep 23, 2026 | neutral | 0 | 0.6 |
| XBIO: Xenetic Biosciences Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits | XBIO: Xenetic Biosciences Inc Latest Stock Price, Analysis, News and Trading Ideas Stocktwits | View source ↗ | Stocktwits | Sep 23, 2026 | neutral | 0 | 0.6 |
| Xenetic Biosciences Announces All-Stock Merger with Santersus, Leaving Existing Shareholders with 15% Stake - Yahoo Finance | Xenetic Biosciences Announces All-Stock Merger with Santersus, Leaving Existing Shareholders with 15% Stake Yahoo Finance | View source ↗ | Yahoo Finance | Sep 16, 2026 | neutral | 0 | 0.6 |
| A planned biotech deal would unite four clinical programs around one disease driver - Stock Titan | A planned biotech deal would unite four clinical programs around one disease driver Stock Titan | View source ↗ | Stock Titan | Sep 16, 2026 | neutral | 0 | 0.6 |
| Xenetic Biosciences, Inc. (NASDAQ:XBIO) To Acquire Santersus in All-Stock Deal; New Ticker 'SNTS' Planned - TradingView | Xenetic Biosciences, Inc. (NASDAQ:XBIO) To Acquire Santersus in All-Stock Deal; New Ticker 'SNTS' Planned TradingView | View source ↗ | TradingView | Sep 16, 2026 | neutral | 0 | 0.6 |
| Xenetic Biosciences (XBIO) Slips to $4.25 While Defending Key Support Zone - ETF Outflow Streak - https://www.siam.in/ | Xenetic Biosciences (XBIO) Slips to $4.25 While Defending Key Support Zone - ETF Outflow Streak https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Sep 9, 2026 | neutral | 0 | 0.6 |
| Xenetic Biosciences (XBIO) Slips to $4.25 While Defending Key Support Zone - Growth ETF - dars.gov.et | Xenetic Biosciences (XBIO) Slips to $4.25 While Defending Key Support Zone - Growth ETF dars.gov.et | View source ↗ | dars.gov.et | Sep 9, 2026 | neutral | 0 | 0.6 |
| XBIO Q2 2025 Earnings: Narrower-Than-Expected Loss Drives Stock Higher - Tangible Book Value - https://www.dars.gov.et/ | XBIO Q2 2025 Earnings: Narrower-Than-Expected Loss Drives Stock Higher - Tangible Book Value https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Jul 21, 2026 | neutral | 0 | 0.6 |
| XBIO Q2 2025 Earnings: Narrower-Than-Expected Loss Drives Stock Higher - GAAP Earnings Report - www.dars.gov.et | XBIO Q2 2025 Earnings: Narrower-Than-Expected Loss Drives Stock Higher - GAAP Earnings Report www.dars.gov.et | View source ↗ | www.dars.gov.et | Jul 21, 2026 | neutral | 0 | 0.6 |
| Xenetic Biosciences (XBIO) Slides 1% as Shares Approach Key Support - Size Factor - dars.gov.et | Xenetic Biosciences (XBIO) Slides 1% as Shares Approach Key Support - Size Factor dars.gov.et | View source ↗ | dars.gov.et | Jul 17, 2026 | neutral | 0 | 0.6 |
| Should I buy Xenetic Biosciences (XBIO) - Zacks Investment Research | Should I buy Xenetic Biosciences (XBIO) Zacks Investment Research | View source ↗ | Zacks Investment Research | Oct 30, 2025 | neutral | 0 | 0.6 |
| Xenetic Biosciences (XBIO) Stock Price, News & Analysis - Stock Titan | Xenetic Biosciences (XBIO) Stock Price, News & Analysis Stock Titan | View source ↗ | Stock Titan | Apr 24, 2025 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Feb 14, 2024 | neutral | 0 | 0.6 |
| Xenetic: XBIO Stock Price Quote & News - Robinhood | Xenetic: XBIO Stock Price Quote & News Robinhood | View source ↗ | Robinhood | Sep 18, 2023 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.